22 COVID-19 vaccines enter clinical trials in China: health official
Xinhua |
Updated: 2021-07-08 19:36
Share
Share - WeChat
BEIJING - Twenty-two COVID-19 vaccines have been approved to enter clinical trials in China, a health official said Thursday.
To date, four COVID-19 vaccines have been granted conditional marketing approval and three have been authorized for emergency use within the country, said Yuan Lin, an official with the National Medical Products Administration (NMPA), at a press conference in Beijing.
By the end of June, the NMPA had granted emergency approval for clinical trials to 25 drugs intended for the treatment of COVID-19 and its indications, Yuan added.
- China launches first national standard on school meal services
- China's nano 'two-photon factory' sets world record
- Low-altitude transit route links Shanghai, Jiangsu
- Shanghai-Hong Kong Youth Choir Festival launches
- Chinese courts step up efforts to safeguard stability
- Former tech group executive sentenced for bribery
